Preclinical biotech developing a lipidated chemerin peptide for dry eye disease.
Industry: Health Care
Latest Trade: $1.06 0.00 (0.0%)
First Day Return: -9.5%
Return from IPO: -73.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/04/2022 |
Offer Price | $4.00 |
Price Range $4.00 - $4.00 | |
Offer Shares (mm) | 0.6 |
Deal Size ($mm) | $3 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/16/2022 |
Offer Price | $4.00 |
Price Range $4.00 - $4.00 | |
Offer Shares (mm) | 0.6 |
Deal Size ($mm) | $3 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
ThinkEquity |
Company Data | |
---|---|
Headquarters | London, United Kingdom |
Founded | 2007 |
Employees at IPO | 2 |
Website www.okyopharma.com |